Tech Center 1600 • Art Units: 1600 1633 1634 1638
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17603355 | Gene Therapy of Fibroblast Growth Factor 23 Related Hypophosphatemic Diseases | Final Rejection | Universite d'Evry Val d'Essonne |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy